[go: up one dir, main page]

MXPA04005158A - Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol. - Google Patents

Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol.

Info

Publication number
MXPA04005158A
MXPA04005158A MXPA04005158A MXPA04005158A MXPA04005158A MX PA04005158 A MXPA04005158 A MX PA04005158A MX PA04005158 A MXPA04005158 A MX PA04005158A MX PA04005158 A MXPA04005158 A MX PA04005158A MX PA04005158 A MXPA04005158 A MX PA04005158A
Authority
MX
Mexico
Prior art keywords
optionally substituted
adenosine
heteroaryldiyl
heteroaryl
disease
Prior art date
Application number
MXPA04005158A
Other languages
English (en)
Inventor
Hong Liu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA04005158A publication Critical patent/MXPA04005158A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Los compuestos que tienen la formula estructural I(ver formula I)en la cual: n es 0, 1, 2 o 3; A es C(R1) o N; R1 y R1a son H, alquilo (C1-C6), halo, CN o -CF3; X es -C(O)-, -O-, -SO0-2- o amileno, heteroarildiilo optativamente sustituidos o heterocicloalquilo con contenido de nitrogeno o, con ciertas condiciones, un enlace; R es arilo o heteroarilo optativamente sustituidos; y R2 es arilo, heteroarilo, arilalquilo o heteroarilalquilo sustituidos optativamente; o R2-Y es un piperidinilo fusionado, piperazinilo sustituido o piperidinilo sustituido; su uso en el tratamiento de la enfermedad de Parkinson, solo o en combinacion con otros agentes para el tratamiento de la enfermedad de Parkinson, composiciones farmaceuticas que los comprenden y equipos que comprenden los componentes de las combinaciones.
MXPA04005158A 2001-11-30 2002-11-26 Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol. MXPA04005158A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33438501P 2001-11-30 2001-11-30
PCT/US2002/037915 WO2003048163A1 (en) 2001-11-30 2002-11-26 [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
MXPA04005158A true MXPA04005158A (es) 2004-08-11

Family

ID=23306955

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005158A MXPA04005158A (es) 2001-11-30 2002-11-26 Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol.

Country Status (18)

Country Link
US (2) US6875772B2 (es)
EP (1) EP1453836B1 (es)
JP (2) JP4429724B2 (es)
KR (1) KR20050044600A (es)
CN (1) CN1688581A (es)
AR (1) AR037681A1 (es)
AT (1) ATE358130T1 (es)
AU (1) AU2002352933A1 (es)
CA (1) CA2468658C (es)
DE (1) DE60219196T2 (es)
ES (1) ES2283625T3 (es)
HU (1) HUP0402324A3 (es)
IL (1) IL161573A0 (es)
MX (1) MXPA04005158A (es)
PE (1) PE20030653A1 (es)
TW (1) TW200300689A (es)
WO (1) WO2003048163A1 (es)
ZA (1) ZA200404168B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002352933A1 (en) * 2001-11-30 2003-06-17 Schering Corporation [1,2,4]-triazole bicylic adenosine A2a receptor antagonists
TW200300686A (en) 2001-11-30 2003-06-16 Schering Corp Adenosine A2a receptor antagonists
CA2477906A1 (en) * 2002-03-12 2003-09-25 Ivo Jirkovsky Process for making chiral 1,4-disubstituted piperazines
AU2003272886A1 (en) * 2002-09-24 2004-04-19 Kyowa Hakko Kogyo Co., Ltd. (1,2,4)-TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVE
NZ540493A (en) 2002-12-19 2008-04-30 Schering Corp Uses of adenosine A2a receptor antagonists
US7285550B2 (en) 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
EP1633756B1 (en) 2003-04-09 2008-12-24 Biogen Idec MA Inc. A2a adenosine receptor antagonists
EP1615931A1 (en) 2003-04-09 2006-01-18 Biogen Idec MA Inc. Triazolopyrazines and methods of making and using the same
WO2004092172A2 (en) * 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists
TW200507850A (en) 2003-07-25 2005-03-01 Kyowa Hakko Kogyo Kk Pharmaceutical composition
JPWO2006129626A1 (ja) * 2005-05-30 2009-01-08 協和醗酵工業株式会社 ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
WO2006132275A1 (ja) * 2005-06-07 2006-12-14 Kyowa Hakko Kogyo Co., Ltd. 運動障害の予防および／または治療剤
US20090124663A1 (en) * 2005-06-08 2009-05-14 Neurosearch A/S Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200803856A (en) 2005-09-02 2008-01-16 Mount Cook Biosciences Inc Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
CN102014959B (zh) 2008-03-10 2016-01-20 康奈尔大学 血脑屏障通透性的调节
WO2010008775A1 (en) * 2008-06-23 2010-01-21 Ligand Pharmaceuticals Inc. Aminopyridopyrazinone derivatives for treating neurodegenerative diseases
GB201214106D0 (en) * 2012-08-07 2012-09-19 Univ Strathclyde Immunomodulatory compounds
WO2017173067A1 (en) 2016-03-31 2017-10-05 Versi Group, Llc Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease
CN106866582A (zh) * 2017-01-10 2017-06-20 广州隽沐生物科技有限公司 一种氟班色林中间体的制备方法
KR102633145B1 (ko) * 2018-06-26 2024-02-05 쩌지앙 빔그린 파머슈티컬스, 엘티디 A2a 수용체 길항제로서의 트리아졸로 트리아진 유도체
WO2020227156A1 (en) * 2019-05-03 2020-11-12 Nektar Therapeutics Adenosine 2 receptor antagonists
EP4083044A4 (en) * 2019-12-26 2024-03-27 Zhejiang Vimgreen Pharmaceuticals, Ltd USE OF A TRIAZOLOTRIAZINE DERIVATIVE IN THE TREATMENT OF DISEASES
WO2022224180A1 (en) * 2021-04-23 2022-10-27 Chong Kun Dang Pharmaceutical Corp. Compound as adenosine a2a receptor antagonist and pharmaceutical composition comprising same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
ATE208199T1 (de) * 1993-07-27 2001-11-15 Kyowa Hakko Kogyo Kk Arzneimittel gegen parkinsonsche krankheit
IT1277392B1 (it) 1995-07-28 1997-11-10 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
JP4195729B2 (ja) * 1997-03-24 2008-12-10 協和醗酵工業株式会社 ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体
IT1291372B1 (it) 1997-05-21 1999-01-07 Schering Plough S P A Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
WO1999043678A1 (en) * 1998-02-24 1999-09-02 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for parkinson's disease
CA2344828A1 (en) * 1998-09-22 2000-03-30 Tomoyuki Kanda ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives
US6355653B1 (en) 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
JP2002037787A (ja) * 2000-05-16 2002-02-06 Kyowa Hakko Kogyo Co Ltd ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
SK287748B6 (sk) 2000-05-26 2011-08-04 Schering Corporation Substituované 5-amino-pyrazolo[4,3-e]-1,2,4-triazolo[1,5- c]pyrimidíny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
EP1435960B1 (en) * 2001-10-15 2014-07-30 Merck Sharp & Dohme Corp. Imidazo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as adenosine a2a receptor antagonists
AU2002352933A1 (en) * 2001-11-30 2003-06-17 Schering Corporation [1,2,4]-triazole bicylic adenosine A2a receptor antagonists

Also Published As

Publication number Publication date
ATE358130T1 (de) 2007-04-15
HUP0402324A3 (en) 2008-09-29
CA2468658C (en) 2009-04-14
JP2005511697A (ja) 2005-04-28
US20050113380A1 (en) 2005-05-26
AR037681A1 (es) 2004-12-01
US7078408B2 (en) 2006-07-18
US6875772B2 (en) 2005-04-05
IL161573A0 (en) 2004-09-27
AU2002352933A1 (en) 2003-06-17
HK1064097A1 (en) 2005-01-21
PE20030653A1 (es) 2003-08-04
DE60219196T2 (de) 2008-01-03
US20030191130A1 (en) 2003-10-09
DE60219196D1 (de) 2007-05-10
ZA200404168B (en) 2005-09-02
ES2283625T3 (es) 2007-11-01
EP1453836B1 (en) 2007-03-28
HUP0402324A2 (hu) 2005-02-28
WO2003048163A1 (en) 2003-06-12
JP4429724B2 (ja) 2010-03-10
TW200300689A (en) 2003-06-16
CN1688581A (zh) 2005-10-26
EP1453836A1 (en) 2004-09-08
KR20050044600A (ko) 2005-05-12
CA2468658A1 (en) 2003-06-12
JP2010018634A (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
MXPA04005158A (es) Antagonistas receptores de adenosina a2a biciclica de (1.2.4]- triazol.
IL150085A0 (en) New-p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
WO2005027966A3 (en) Antibodies with altered effector functions
EP1432714A4 (en) CHEMICAL COMPOUNDS
IL197484A0 (en) 5-AMINO-7-(1H-INDOL-2-YL)-1,3-DIHYDRO-IMIDAZOL[4,5-b]PYRIDIN-2-ONE AND ITS N- BOC PROTECTED-7-(1H-INDOL-2-YL)-2-METHYL-3H-IMIDAZO[4,5-b]PYRIDIN-5-YLAMINE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
IL180722A0 (en) Thienopyrimidine derivatives and pharmaceutical compositions containing the same
DE60212801D1 (de) Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
BRPI0408817A (pt) composto, processo de preparação do mesmo, composição farmacêutico, e, utilização de um composto
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
SE9902765D0 (sv) Novel compounds
DE60224777D1 (de) Quarzglasblock, synthetisches Quarzglas und Verfahren zu dessen Herstellung
SE9902551D0 (sv) Novel compounds
PT916670E (pt) Pirrolo-(3,2-b) piridinas e o seu uso como agonistas do 5-ht1f
DE60215790D1 (de) Uv-absorber für kunstharz und diesen enthaltende kunstharzzusammensetzung
MXPA04005151A (es) Compuestos terapeuticos.
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
EP1436279A4 (en) CHEMICAL COMPOUNDS
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
AP1579A (en) Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same.
MXPA05013035A (es) Derivados de aroilsemicarbazida.
SE0004098D0 (sv) Novel compounds
WO2003027295A3 (en) Methods for diagnosis and treatment of diseases associated with altered expression of jak1
MX2007003472A (es) Derivados de prolina.

Legal Events

Date Code Title Description
FG Grant or registration